İlkay Başak UYSAL | Senior Project Manager
INSERM

İlkay Başak UYSAL, Senior Project Manager, INSERM

Başak Uysal (Dr, PhD) is Project Manager of the Data Service Hub within the European Rare Diseases Research Alliance (ERDERA) coordination team, where she works at the intersection of rare disease research, data infrastructures and collaborative innovation. With a background in molecular biology, bioinformatics and public health, her work focuses on making rare disease data more FAIR, interoperable and usable across organisational and national boundaries, including through federated approaches and European research infrastructures. She coordinates collaborations involving researchers, clinicians, patient organisations, research infrastructures, industry and public-sector stakeholders. As co-moderator of “ERDERA: AI for Rare Diseases: From Promise to Practice”, Başak will help guide a multidisciplinary conversation beyond the hype around AI, focusing on where it can create tangible value for rare disease research and therapeutic development, where its limitations remain, and how AI and human expertise can most effectively complement one another.

Appearances:



Pre-congress workshops @ 11:30

ERDERA: AI for Rare Diseases: From Promise to Practice

Artificial intelligence is rapidly becoming an integral part of the rare disease ecosystem, supporting scientific discovery, therapeutic development and strategic decision-making. Yet, beyond the headlines, important questions remain: where does AI genuinely create value, where does it still fall short, and how can it best complement, not replace, human expertise?

This interactive workshop will bring together leaders from research, biotech, pharmaceutical industry, investment and the patient community to explore how AI is already transforming rare disease innovation. Through real-world examples and multidisciplinary discussions, participants will examine both the opportunities and the practical limitations of AI, and discuss how human intelligence and artificial intelligence can work together to accelerate the development of therapies for rare diseases.

last published: 27/Oct/26 13:03 GMT

back to speakers